Obamacare

NLPC Shareholder Proposal Challenges Pfizer's Support of ObamaCare

Ian Read photoNLPC has filed a shareholder proposal challenging Pfizer's support for ObamaCare. The resolution actually asks for a report on Pfizer's lobbying priorities. Here is the supporting statement submitted to Pfizer for inclusion in the proxy:

Pfizer played a key role in the passage of ObamaCare, even though a majority of Americans were opposed. CEO Jeffrey Kindler organized pharmaceutical CEOs in support of the bill, promoted a massive advertising campaign, and partnered with Left-wing groups normally hostile to Pfizer's interests. For these actions, he received a multi-million dollar bonus.

Obamacare Covert Bailout Should be Scrutinized

Back in April of this year I wrote about the covert bailout that was buried in the Obamacare bill which gives $5 billion of taxpayer money to unions, states (for public employees) and corporations for health care coverage for retirees aged between 55 and 64. The program is called the Early Retiree Reinsurance Program or ERRP. The UAW is the largest single beneficiary, receiving over 200 million dollars. General Motors also gets a piece of the pork with about a 20 million dollar cut. A recent report by the Washington Examiner identifies early retirees (many of whom are being paid over $100,000 a year in pension payments) of the California Public Employees Retirement System (CalPERS) as the other top recipient of about 200 million dollars.

Walmart-Endorsed Obamacare Can't Save Employees from Skyrocketing Insurance Costs

Mike Duke photoWe told you so. Last week Walmart announced it will severely cut back health benefits for its employees, proving that the Obamacare law that the company endorsed will not save the day for its many low-income workers.

Under the new company policy, new part-time associates will no longer be eligible to receive health insurance. Reuters also reports that the amount Walmart puts in employee healthcare savings accounts will be cut in half.

Pfizer CEO Refuses to Repudiate Support for ObamaCare at Annual Meeting

Ian Read photoUnder questioning by me, Pfizer CEO Ian Read refused to repudiate the company's support for ObamaCare at the company's annual meeting today in Dallas. The exchange took place after my remarks in favor our shareholder proposal on the company's lobbying priorities.

When I asked Read if the company would drop its support for ObamaCare, he gave me a summary of what the company considers important in health care reform without directly answering. I said, "Sir, will you answer my question? A 'yes' or 'no' will do." Read rambled further and I responded by saying, "But have already cast your lot with one side." Finally, I said "I will take it as a 'no.' Thank you." Here are my remarks in favor of our proposal:

Pfizer Support for ObamaCare to be Challenged at Annual Meeting

Pfizer logoI will speak in favor of our shareholder proposal spotlighting Pfizer's deal with the White House to support ObamaCare at the company's annual meeting on Thursday, April 28 at the Renaissance Hotel in Dallas, Texas. The resolution itself asks for a report on Pfizer's lobbying priorities. Our supporting statement in the Pfizer proxy reads, in part:

Walmart Has NOT Disavowed Political Correctness

Leslie DachOn Monday Walmart, which has been the subject of much criticism from the National Legal and Policy Center for kowtowing to liberal causes such as cap-and-trade and Obamacare, announced it is going to “reinforce its commitment to deliver low prices.”

No seriously. They really mean it. This time.

Pfizer CEO Jeffrey Kindler Resigns Even Sooner Than We Predicted

Kindler photoPfizer CEO Jeffrey Kindler has unexpectedly announced his resignation. NLPC recently filed a shareholder proposal with Pfizer critical of the company's deal with the White House to support ObamaCare. We foresaw Kindler's retirement in the resolution's supporting statement:

If ObamaCare fails to control health care costs, as several studies now suggest, the government will seek savings through price controls. Shareholders ultimately will lose. Perhaps Kindler plans to retire before Pfizer is required to sell its products for less than the cost of production.

We were more prescient than we realized.

Corporate CEOs Must Heed Election Results, Too

Kindler photoThe electorate’s repudiation of Barack Obama and his Congressional allies was not only a rejection of Big Government, but also of business elites who were buffeted from the downturn by political dealing at the expense of ordinary people.

Unless Corporate America heeds the election results, it too will risk the wrath of an informed and energized public. Here are CEOs who must pay attention to what happened yesterday:

Pfizer CEO Jeffrey Kindler- Not only did Kindler (above) lead the charge of Big Pharma CEOs for ObamaCare, he actually got a multi-million dollar bonus from Pfizer for doing so. This is not going to look very good once ObamaCare spikes insurance premiums, prompts hospital closures, and explodes the number of uninsured. Of course, Kindler wasn’t naïve or confused, he had reason to help destroy the health system. Big Pharma made a deal that guarantees it customers and insulation from competition. (I assume Kindler plans to retire before the government forces Pfizer to sell its products for less than it costs to produce them.)

Flaherty Blasts Wal-Mart on Fox News Channel

On Friday afternoon, I discussed Wal-Mart's support for ObamaCare and Cap and Trade with guest host Connell McShane on Your World With Neil Cavuto on Fox News Channel. That morning, I spoke in favor of our shareholder proposal asking for a report on Wal-Mart's lobbying priorities at the company's annual meeting in Fayetteville, Arkansas. Here's a transcript of the interview:

Wal-Mart Support for ObamaCare, Cap and Trade Ripped at Annual Meeting

Here is a video of my remarks at the Wal-Mart annual meeting at the Bud Walton Arena in Fayetteville, Arkansas in support of our shareholder proposal asking Wal-Mart for a report on its lobbying priorities. Here is the text of my remarks:

Syndicate content